Chronic myeloid leukemia (CML) is a stem cell‐driven neoplasia characterized by the expression of the constitutively active tyrosine kinase (TK) BCR/Abl. The gene discussed is TKT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.